{"entity":{"type":"insider","cik":"0001650504","url":"/insider/0001650504","json_url":"/insider/0001650504.json","name":"Rolfe Lindsey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":39,"first":"2015-10-07","last":"2022-11-03","span_basis":"filed_date"},"name_variants":[{"name":"Rolfe Lindsey","source":"filing","n_filings":39,"first_seen":"2015-10-07","last_seen":"2022-11-03"}],"transactions":[{"id":6714865,"accession":"0000899243-22-034890","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-034890","line_url":"/filing/0000899243-22-034890","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4261.0,"shares_display":"4,261","price_per_share":0.9829,"price_display":"0.98","price_state":"stated","total_value":4188.1369,"total_display":"4,188.14","total_whole":"4,188","shares_owned_after":113691.0,"shares_owned_after_display":"113,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider","n_lines":2},{"id":6117789,"accession":"0000899243-22-030421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030421","line_url":"/filing/0000899243-22-030421#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2545.0,"shares_display":"2,545","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":3054.0,"total_display":"3,054.00","total_whole":"3,054","shares_owned_after":109578.0,"shares_owned_after_display":"109,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6974388,"accession":"0000899243-22-027577","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027577","line_url":"/filing/0000899243-22-027577","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4330.0,"shares_display":"4,330","price_per_share":1.4609,"price_display":"1.46","price_state":"stated","total_value":6325.697,"total_display":"6,325.70","total_whole":"6,326","shares_owned_after":107060.0,"shares_owned_after_display":"107,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6741432,"accession":"0000899243-22-020946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020946","line_url":"/filing/0000899243-22-020946#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":0.6425,"price_display":"0.64","price_state":"stated","total_value":1702.625,"total_display":"1,702.62","total_whole":"1,703","shares_owned_after":103016.0,"shares_owned_after_display":"103,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6318316,"accession":"0000899243-22-016295","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016295","line_url":"/filing/0000899243-22-016295","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4252.0,"shares_display":"4,252","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":8375.5896,"total_display":"8,375.59","total_whole":"8,376","shares_owned_after":100604.0,"shares_owned_after_display":"100,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider","n_lines":2},{"id":6560035,"accession":"0000899243-22-009062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-009062","line_url":"/filing/0000899243-22-009062","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10945.0,"shares_display":"10,945","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":20423.37,"total_display":"20,423.37","total_whole":"20,423","shares_owned_after":96482.0,"shares_owned_after_display":"96,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":6767140,"accession":"0000899243-22-004583","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-004583","line_url":"/filing/0000899243-22-004583","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4514.0,"shares_display":"4,514","price_per_share":1.9396552281789987,"price_display":"1.94","price_state":"stated","total_value":8755.6037,"total_display":"8,755.60","total_whole":"8,756","shares_owned_after":86489.0,"shares_owned_after_display":"86,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider","n_lines":2},{"id":4307334,"accession":"0000899243-21-046772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046772","line_url":"/filing/0000899243-21-046772#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":346.0,"shares_display":"346","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":1038.0,"total_display":"1,038.00","total_whole":"1,038","shares_owned_after":82628.0,"shares_owned_after_display":"82,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider"},{"id":4307018,"accession":"0000899243-21-042707","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-042707","line_url":"/filing/0000899243-21-042707","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4209.0,"shares_display":"4,209","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":19150.95,"total_display":"19,150.95","total_whole":"19,151","shares_owned_after":82287.0,"shares_owned_after_display":"82,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":4123280,"accession":"0000899243-21-035113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-035113","line_url":"/filing/0000899243-21-035113#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1696.83,"total_display":"1,696.83","total_whole":"1,697","shares_owned_after":78122.0,"shares_owned_after_display":"78,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":4451314,"accession":"0000899243-21-031440","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-031440","line_url":"/filing/0000899243-21-031440","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4195.0,"shares_display":"4,195","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":20219.9,"total_display":"20,219.90","total_whole":"20,220","shares_owned_after":77781.0,"shares_owned_after_display":"77,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider","n_lines":2},{"id":5392207,"accession":"0000899243-21-021857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-021857","line_url":"/filing/0000899243-21-021857#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322.0,"shares_display":"322","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":1812.86,"total_display":"1,812.86","total_whole":"1,813","shares_owned_after":73602.0,"shares_owned_after_display":"73,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-03","scope":"insider"},{"id":4508717,"accession":"0000899243-21-018276","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-018276","line_url":"/filing/0000899243-21-018276","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4501.0,"shares_display":"4,501","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":24935.54,"total_display":"24,935.54","total_whole":"24,936","shares_owned_after":73237.0,"shares_owned_after_display":"73,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider","n_lines":2},{"id":4162216,"accession":"0000899243-21-009493","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-009493","line_url":"/filing/0000899243-21-009493","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":661.0,"shares_display":"661","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":4157.69,"total_display":"4,157.69","total_whole":"4,158","shares_owned_after":69364.0,"shares_owned_after_display":"69,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":5391304,"accession":"0000899243-21-004675","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-004675","line_url":"/filing/0000899243-21-004675","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11813.0,"shares_display":"11,813","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":94149.61,"total_display":"94,149.61","total_whole":"94,150","shares_owned_after":68712.0,"shares_owned_after_display":"68,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":3280465,"accession":"0000899243-20-034998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034998","line_url":"/filing/0000899243-20-034998#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1728.0,"shares_display":"1,728","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":9815.04,"total_display":"9,815.04","total_whole":"9,815","shares_owned_after":58275.0,"shares_owned_after_display":"58,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":2385509,"accession":"0000899243-20-032938","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032938","line_url":"/filing/0000899243-20-032938","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":661.0,"shares_display":"661","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":3232.29,"total_display":"3,232.29","total_whole":"3,232","shares_owned_after":53477.0,"shares_owned_after_display":"53,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider","n_lines":2},{"id":2045244,"accession":"0000899243-20-030475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030475","line_url":"/filing/0000899243-20-030475#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1920.0,"shares_display":"1,920","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":9465.6,"total_display":"9,465.60","total_whole":"9,466","shares_owned_after":52826.0,"shares_owned_after_display":"52,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2513361,"accession":"0000899243-20-026086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-026086","line_url":"/filing/0000899243-20-026086","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1747.0,"shares_display":"1,747","price_per_share":6.850120206067545,"price_display":"6.85","price_state":"stated","total_value":11967.16,"total_display":"11,967.16","total_whole":"11,967","shares_owned_after":50997.0,"shares_owned_after_display":"50,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-23","scope":"insider","n_lines":2},{"id":2045106,"accession":"0000899243-20-024506","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-024506","line_url":"/filing/0000899243-20-024506","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":628.0,"shares_display":"628","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":3328.4,"total_display":"3,328.40","total_whole":"3,328","shares_owned_after":49307.0,"shares_owned_after_display":"49,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider","n_lines":2},{"id":2101175,"accession":"0000899243-20-021480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-021480","line_url":"/filing/0000899243-20-021480#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1899.0,"shares_display":"1,899","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":11242.08,"total_display":"11,242.08","total_whole":"11,242","shares_owned_after":48622.0,"shares_owned_after_display":"48,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2507115,"accession":"0000899243-20-017488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017488","line_url":"/filing/0000899243-20-017488#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1728.0,"shares_display":"1,728","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":11646.72,"total_display":"11,646.72","total_whole":"11,647","shares_owned_after":46772.0,"shares_owned_after_display":"46,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-23","scope":"insider"},{"id":2207790,"accession":"0000899243-20-015484","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015484","line_url":"/filing/0000899243-20-015484","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":680.0,"shares_display":"680","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":4780.4,"total_display":"4,780.40","total_whole":"4,780","shares_owned_after":45062.0,"shares_owned_after_display":"45,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider","n_lines":2},{"id":2677784,"accession":"0000899243-20-012237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-012237","line_url":"/filing/0000899243-20-012237#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":13583.7,"total_display":"13,583.70","total_whole":"13,584","shares_owned_after":44430.0,"shares_owned_after_display":"44,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2506661,"accession":"0000899243-20-009258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009258","line_url":"/filing/0000899243-20-009258#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1728.0,"shares_display":"1,728","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":7948.8,"total_display":"7,948.80","total_whole":"7,949","shares_owned_after":36057.0,"shares_owned_after_display":"36,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-23","scope":"insider"},{"id":2592426,"accession":"0000899243-20-007184","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-007184","line_url":"/filing/0000899243-20-007184","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":687.0,"shares_display":"687","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":4946.4,"total_display":"4,946.40","total_whole":"4,946","shares_owned_after":34348.0,"shares_owned_after_display":"34,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider","n_lines":2},{"id":3073945,"accession":"0000899243-20-003479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-003479","line_url":"/filing/0000899243-20-003479#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7503.0,"shares_display":"7,503","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":63100.23,"total_display":"63,100.23","total_whole":"63,100","shares_owned_after":33722.0,"shares_owned_after_display":"33,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":7831428,"accession":"0000899243-19-030054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-030054","line_url":"/filing/0000899243-19-030054#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1729.0,"shares_display":"1,729","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":19537.7,"total_display":"19,537.70","total_whole":"19,538","shares_owned_after":26228.0,"shares_owned_after_display":"26,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-26","scope":"insider"},{"id":8438264,"accession":"0000899243-19-028565","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028565","line_url":"/filing/0000899243-19-028565","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":674.0,"shares_display":"674","price_per_share":14.60047477744807,"price_display":"14.60","price_state":"stated","total_value":9840.72,"total_display":"9,840.72","total_whole":"9,841","shares_owned_after":24519.0,"shares_owned_after_display":"24,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider","n_lines":2},{"id":8197785,"accession":"0000899243-19-024171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-024171","line_url":"/filing/0000899243-19-024171#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1744.0,"shares_display":"1,744","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":8371.2,"total_display":"8,371.20","total_whole":"8,371","shares_owned_after":23881.0,"shares_owned_after_display":"23,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8234182,"accession":"0000899243-19-023015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-023015","line_url":"/filing/0000899243-19-023015","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":716.0,"shares_display":"716","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":3730.36,"total_display":"3,730.36","total_whole":"3,730","shares_owned_after":22188.0,"shares_owned_after_display":"22,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider","n_lines":2},{"id":8340688,"accession":"0000899243-19-017949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-017949","line_url":"/filing/0000899243-19-017949#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1728.0,"shares_display":"1,728","price_per_share":14.7,"price_display":"14.70","price_state":"stated","total_value":25401.6,"total_display":"25,401.60","total_whole":"25,402","shares_owned_after":21591.0,"shares_owned_after_display":"21,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider"},{"id":8091515,"accession":"0000899243-19-015789","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-015789","line_url":"/filing/0000899243-19-015789#line-4","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001650504","owner_name":"Rolfe Lindsey","owner_display_name":"Rolfe Lindsey","owner_url":"/insider/0001650504","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":343.0,"shares_display":"343","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":5169.01,"total_display":"5,169.01","total_whole":"5,169","shares_owned_after":19881.0,"shares_owned_after_display":"19,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"}],"collapsed":true,"next_cursor":"2019-06-04|8091515","ledger_fault":false,"count":{"value":64,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":64,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":64},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":39,"first_seen":"2015-10-07","last_seen":"2022-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650504","retrieved_at":"2026-08-22T05:30:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}